FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Expression of Proteinase-Activated Receptor 2 During Colon V...
Frontiers in veterinary science2020; 7; 589367; doi: 10.3389/fvets.2020.589367

Expression of Proteinase-Activated Receptor 2 During Colon Volvulus in the Horse.

Abstract: Large colon volvulus in horses is associated with a poor prognosis, especially when ischemic-reperfusion injury of the affected intestinal tract develops. Proteinase-activated receptor 2 (PAR2) plays an important role in the pathogenesis of inflammation in the gastrointestinal tract. The aim of this study was to evaluate the distribution and expression of PAR2 in colonic pelvic flexure of horses spontaneously affected by large colon volvulus (CVH group). Eight horses admitted for severe abdominal colon volvolus and which underwent surgery were included. Colon samples were collected after enterotomy. Data previously obtained from healthy horses were used as a control group. Histologic evaluation was carried out to grade the severity of the colon lesions. Immunofluorescence, western blot and quantitative polymerase chain reaction (RT-qPCR) were carried out on colon samples to evaluate PAR2 expression. In addition, the transcriptional profile of cytokines and chemokines was evaluated using RT2 Profiler™ PCR Array Horse Cytokines & Chemokines. Three out of the eight patients were euthanised due to clinical deterioration. Immunostaining for PAR2 was observed in the enterocytes, intestinal glands and neurons of the submucosal and myenteric plexi. In the CVH horses, the expression of PAR2 mesenger RNA (mRNA) did not differ significantly from that of the healthy animals; western blots of the mucosa of the colon tracts showed a clear band of the expected molecular weight for PAR2 (~44 kDa) and a band smaller than the expected molecular weight for PAR2 (25kDa), suggesting its activation. The gene expressions for C-X-C motif ligand 1 (CXCL1); interleukin 8 (IL8), macrophage inflammatory protein 2 beta (MIP-2BETA) were upregulated in the colic horses as compared with the colons of the healthy horses. Therefore, in the present study, the expression and activation of PAR2 in the colons of horses in the presence of an inflammatory reaction like that occurring in those with spontaneous colon volvulus was confirmed.
Copyright © 2020 Lambertini, Zannoni, Romagnoli, Bombardi, Morini, Dondi, Bernardini, Forni, Rinnovati and Spadari.
Get Full Text
Publication Date: 2020-11-27 PubMed ID: 33330716PubMed Central: PMC7728609DOI: 10.3389/fvets.2020.589367Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper is about a study into the Proteinase-Activated Receptor 2 (PAR) involvement in colonic inflammation during colon volvulus in horses, using techniques such as histologic evaluation, immunofluorescence, and western blot assessments.

Objective of the Study

The aim of the study was to investigate the distribution and expression of Proteinase-Activated Receptor 2 (PAR) in colonic pelvic flexure in horses affected by large colon volvulus. This research sought to provide insights into the role of PAR in the inflammation processes in the equine gastrointestinal tract.

Sample Collection and Grouping

  • Eight horses suffering from severe abdominal colon volvulus were included in the study. During the surgery, samples of the colon were collected after enterotomy.
  • Data from healthy horses was used as a control group for comparative analysis.

Method of Evaluation

  • Researchers used histological evaluations to assess the severity of colonic lesions in the seized samples.
  • Immunofluorescence, western blot, and quantitative polymerase chain reaction (RT-qPCR) were performed to evaluate the distribution and the level of expression of PAR.
  • The transcriptional profiling of cytokines and chemokines was done using RT Profiler™ PCR Array Horse Cytokines & Chemokines to compare between the healthy and colic horses.

Key Findings

  • PAR immunostaining was detected in the enterocytes, intestinal glands, and neurons of the submucosal and myenteric plexi. There was no significant difference in the expression of PAR mRNA between the colon volvulus horses and healthy animals.
  • The western blot analysis of the colon’s mucosa showed clear bands of the expected molecular weight for PAR and a smaller band suggesting PAR activation.
  • The study found an uptick in the gene expressions for C-X-C motif ligand 1 (CXCL1); interleukin 8 (IL8), and macrophage inflammatory protein 2 beta (MIP-2BETA) in the colic horses compared to healthy counterparts.

Conclusion of the Study

The study concluded by confirming the expression and activation of PAR in the colons of horses when there is an inflammatory reaction such as occurs in horses with spontaneous colon volvulus. This indicates a significant role of PAR in inflammation in colon volvulus cases.

Cite This Article

APA
Lambertini C, Zannoni A, Romagnoli N, Bombardi C, Morini M, Dondi F, Bernardini C, Forni M, Rinnovati R, Spadari A. (2020). Expression of Proteinase-Activated Receptor 2 During Colon Volvulus in the Horse. Front Vet Sci, 7, 589367. https://doi.org/10.3389/fvets.2020.589367

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 7
Pages: 589367

Researcher Affiliations

Lambertini, Carlotta
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Zannoni, Augusta
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Romagnoli, Noemi
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Bombardi, Cristiano
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Morini, Maria
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Dondi, Francesco
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Bernardini, Chiara
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Forni, Monica
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Rinnovati, Riccardo
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Spadari, Alessandro
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 56 references
  1. Gonzalez LM, Fogle CA, Baker WT, Hughes FE, Law JM, Motsinger-Reif AA. Operative factors associated with short-term outcome in horses with large colon volvulus: 47 cases from 2006 to 2013. Equine Vet J (2015) 47:279–84.
    doi: 10.1111/evj.12273pmc: PMC4198525pubmed: 24735170google scholar: lookup
  2. Johnston JK, Freeman DE. Diseases and surgery of the large colon. Vet Clin North Am Equine Pract (1997) 13:317–40.
    doi: 10.1016/S0749-0739(17)30242-0pubmed: 9290186google scholar: lookup
  3. Suthers JM, Pinchbeck GL, Proudman CJ, Archer DC. Survival of horses following strangulating large colon volvulus. Equine Vet J (2013) 45:219–23.
    doi: 10.1111/j.2042-3306.2012.00620.xpubmed: 22994687google scholar: lookup
  4. Grosche A, Morton AJ, Graham AS, Valentine JF, Abbott JR, Polyak MM. Mucosal injury and inflammatory cells in response to brief ischaemia and reperfusion in the equine large colon. Equine Vet J Suppl (2011) 16–25.
    doi: 10.1111/j.2042-3306.2011.00415.xpubmed: 21790750google scholar: lookup
  5. Monreal L, Cesarini C. Coagulopathies in horses with colic. Vet Clin North Am Equine Pract (2009) 25:247–58.
    doi: 10.1016/j.cveq.2009.04.001pubmed: 19580937google scholar: lookup
  6. Raithel M, Winterkamp S, Pacurar A, Ulrich P, Hochberger J, Hahn EG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol (2001) 36:174–9.
    doi: 10.1080/003655201750065933pubmed: 11252410google scholar: lookup
  7. Gobbetti T, Cenac N, Motta JP, Rolland C, Martin L, Andrade-Gordon P. Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine. Am J Pathol (2012) 180:141–52.
    doi: 10.1016/j.ajpath.2011.09.031pmc: PMC5818635pubmed: 22067907google scholar: lookup
  8. Jimenez-Vargas NN, Pattison LA, Zhao P, Lieu T, Latorre R, Jensen DD. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome. Proc Natl Acad Sci USA (2018) 115:E7438–E47.
    doi: 10.1073/pnas.1721891115pmc: PMC6077730pubmed: 30012612google scholar: lookup
  9. Vergnolle N. Clinical relevance of proteinase activated receptors (pars) in the gut. Gut (2005) 54:867–74.
    doi: 10.1136/gut.2004.048876pmc: PMC1774539pubmed: 15888798google scholar: lookup
  10. MacNaughton WK. Epithelial effects of proteinase-activated receptors in the gastrointestinal tract. Mem Inst Oswaldo Cruz (2005) 100(Suppl 1):211–5.
    doi: 10.1590/S0074-02762005000900036pubmed: 15962125google scholar: lookup
  11. Zhang Y, Ge T, Xiang P, Mao H, Tang S, Li A. Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH2 on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism. Drug Des Devel Ther (2018) 12:2403–11.
    doi: 10.2147/DDDT.S160628pmc: PMC6078190pubmed: 30122898google scholar: lookup
  12. Pontarollo G, Mann A, Brandão I, Malinarich F, Schöpf M, Reinhardt C. Protease-activated receptor signaling in intestinal permeability regulation. FEBS J (2020) 287:645–58.
    doi: 10.1111/febs.15055pubmed: 31495063google scholar: lookup
  13. Vergnolle N. Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther (2000) 14:257–66.
    doi: 10.1046/j.1365-2036.2000.00690.xpubmed: 10735917google scholar: lookup
  14. Amadesi S, Bunnett N. Protease-activated receptors: protease signaling in the gastrointestinal tract. Curr Opin Pharmacol (2004) 4:551–56.
    doi: 10.1016/j.coph.2004.08.004pubmed: 15525542google scholar: lookup
  15. Kawabata A, Matsunami M, Sekiguchi F. Gastrointestinal roles for proteinase-activated receptors in health and disease. Br J Pharmacol (2008) 153(Suppl. 1):S230–40.
    doi: 10.1038/sj.bjp.0707491pmc: PMC2268065pubmed: 17994114google scholar: lookup
  16. Caminero A, McCarville JL, Galipeau HJ, Deraison C, Bernier SP, Constante M. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun (2019) 10:1198.
    doi: 10.1038/s41467-019-09037-9pmc: PMC6416356pubmed: 30867416google scholar: lookup
  17. Romagnoli N, Zannoni A, Bernardini C, Gobbetti T, Bombardi C, Rambaldi A. Proteinase-activated receptor 2 distribution and expression in equine small intestine tracts following herniation through the epiploic foramen. Res Vet Sci (2019) 125:434–40.
    doi: 10.1016/j.rvsc.2017.10.006pubmed: 29108655google scholar: lookup
  18. Zannoni A, Bombardi C, Dondi F, Morini M, Forni M, Chiocchetti R. Proteinase-activated receptor 2 expression in the intestinal tract of the horse. Res Vet Sci (2014) 96:464–71.
    doi: 10.1016/j.rvsc.2014.03.006pubmed: 24656343google scholar: lookup
  19. Van Hoogmoed L, Snyder JR, Pascoe JR, Olander H. Use of pelvic flexure biopsies to predict survival after large colon torsion in horses. Vet Surg (2000) 29:572–7.
    doi: 10.1053/jvet.2000.17836pubmed: 11098791google scholar: lookup
  20. Levi O, Affolter VK, Benak J, Kass PH, Le Jeune SS. Use of pelvic flexure biopsy scores to predict short-term survival after large colon volvulus. Vet Surg (2012) 41:582–8.
    doi: 10.1111/j.1532-950X.2012.00994.xpubmed: 22571759google scholar: lookup
  21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (2001) 25:402–8.
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  22. Driscoll N, Baia P, Fischer AT, Brauer T, Klohnen A. Large colon resection and anastomosis in horses: 52 cases (1996-2006). Equine Vet J (2008) 40:342–47.
    doi: 10.2746/042516408X293529pubmed: 18321811google scholar: lookup
  23. Hackett ES, Embertson RM, Hopper SA, Woodie JB, Ruggles AJ. Duration of disease influences survival to discharge of thoroughbred mares with surgically treated large colon volvulus. Equine Vet J (2015) 47:650–4.
    doi: 10.1111/evj.12358pubmed: 25257041google scholar: lookup
  24. Grosche A, Morton AJ, Graham AS, Polyak MM, Freeman DE. Effect of large colon ischemia and reperfusion on concentrations of calprotectin and other clinicopathologic variables in jugular and colonic venous blood in horses. Am J Vet Res (2013) 74:1281–90.
    doi: 10.2460/ajvr.74.10.1281pubmed: 24066912google scholar: lookup
  25. Vandenplas ML, Moore JN, Barton MH, Roussel AJ, Cohen ND. Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic. Am J Vet Res (2005) 66:1509–16.
    doi: 10.2460/ajvr.2005.66.1509pubmed: 16261823google scholar: lookup
  26. Dondi F, Lukacs RM, Gentilini F, Rinnovati R, Spadari A, Romagnoli N. Serum amyloid A, haptoglobin, and ferritin in horses with colic: association with common clinicopathological variables and short-term outcome. Vet J (2015) 205:50–5.
    doi: 10.1016/j.tvjl.2015.03.015pubmed: 25981935google scholar: lookup
  27. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol (1994) 144:997–1007.
    pmc: PMC1887375pubmed: 8178948
  28. Egesten A, Eliasson M, Olin AI, Erjefält JS, Bjartell A, Sangfelt P. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int J Colorectal Dis (2007) 22:1421–7.
    doi: 10.1007/s00384-007-0370-3pubmed: 17703315google scholar: lookup
  29. Vergnolle N. The enteric nervous system in inflammation and pain: the role of proteinase-activated receptors. Can J Gastroenterol (2003) 17:589–92.
    doi: 10.1155/2003/683731pubmed: 14571293google scholar: lookup
  30. Cattaruzza F, Cenac N, Barocelli E, Impicciatore M, Hyun E, Vergnolle N. Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents. Am J Pathol (2006) 169:177–88.
    doi: 10.2353/ajpath.2006.051098pmc: PMC1698753pubmed: 16816371google scholar: lookup
  31. Zhao JH, Dong L, Shi HT, Wang ZY, Shi HY, Ding H. The expression of protease-activated receptor 2 and 4 in the colon of irritable bowel syndrome patients. Dig Dis Sci (2012) 57:58–64.
    doi: 10.1007/s10620-011-1827-3pubmed: 21800160google scholar: lookup
  32. Iablokov V, Hirota CL, Peplowski MA, Ramachandran R, Mihara K, Hollenberg MD. Proteinase-activated receptor 2 (PAR2) decreases apoptosis in colonic epithelial cells. J Biol Chem (2014) 289:34366–77.
    doi: 10.1074/jbc.M114.610485pmc: PMC4256365pubmed: 25331954google scholar: lookup
  33. Nguyen C, Coelho AM, Grady E, Compton SJ, Wallace JL, Hollenberg MD. Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism. Can J Physiol Pharmacol (2003) 81:920–7.
    doi: 10.1139/y03-080pubmed: 14614531google scholar: lookup
  34. Yoshida N, Yoshikawa T. Basic and translational research on proteinase-activated receptors: implication of proteinase/proteinase-activated receptor in gastrointestinal inflammation. J Pharmacol Sci (2008) 108:415–21.
    doi: 10.1254/jphs.08R31FMpubmed: 19098387google scholar: lookup
  35. Yoshida N, Takagi T, Isozaki Y, Suzuki T, Ichikawa H, Yoshikawa T. Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats. Mol Med Rep (2011) 4:81–6.
    doi: 10.3892/mmr.2010.386pubmed: 21461568google scholar: lookup
  36. Ghouzali I, Azhar S, Bôle-Feysot C, Ducrotté P, Déchelotte P, Coëffier M. Proteasome inhibitors exacerbate interleukin-8 production induced by protease-activated receptor 2 in intestinal epithelial cells. Cytokine (2016) 86:41–6.
    doi: 10.1016/j.cyto.2016.07.014pubmed: 27455449google scholar: lookup
  37. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev (2004) 84:579–621.
    doi: 10.1152/physrev.00028.2003pubmed: 15044683google scholar: lookup
  38. Temkin V, Kantor B, Weg V, Hartman ML, Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol (2002) 169:2662–9.
    doi: 10.4049/jimmunol.169.5.2662pubmed: 12193739google scholar: lookup
  39. Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol (1996) 156:275–83.
    pubmed: 8598474
  40. Howells GL, Macey MG, Chinni C, Hou L, Fox MT, Harriott P. Proteinase-activated receptor-2: expression by human neutrophils. J Cell Sci (1997) 110:881–7.
    pubmed: 9133675
  41. Compton SJ, Cairns JA, Holgate ST, Walls AF. Human mast cell tryptase stimulates the release of an IL-8-dependent neutrophil chemotactic activity from human umbilical vein endothelial cells (HUVEC). Clin Exp Immunol (2000) 121:31–6.
    doi: 10.1046/j.1365-2249.2000.01271.xpmc: PMC1905680pubmed: 10886236google scholar: lookup
  42. Hirota Y, Osuga Y, Hirata T, Harada M, Morimoto C, Yoshino O. Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod (2005) 20:3547–53.
    doi: 10.1093/humrep/dei255pubmed: 16096323google scholar: lookup
  43. Yoshida N, Katada K, Handa O, Takagi T, Kokura S, Naito Y. Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int J Mol Med (2007) 19:335–40.
    doi: 10.3892/ijmm.19.2.335pubmed: 17203209google scholar: lookup
  44. Kajikawa H, Yoshida N, Katada K, Hirayama F, Handa O, Kokura S. Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2. Digestion (2007) 76:248–55.
    doi: 10.1159/000113041pubmed: 18196899google scholar: lookup
  45. Ohtsuka Y, Lee J, Stamm DS, Sanderson IR. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut (2001) 49:526–33.
    doi: 10.1136/gut.49.4.526pmc: PMC1728474pubmed: 11559650google scholar: lookup
  46. Spehlmann ME, Dann SM, Hruz P, Hanson E, McCole DF, Eckmann L. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J Immunol (2009) 183:3332–43.
    doi: 10.4049/jimmunol.0900600pmc: PMC3419829pubmed: 19675161google scholar: lookup
  47. Ohno Y, Lee J, Fusunyan RD, MacDermott RP, Sanderson IR. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. Proc Natl Acad Sci USA (1997) 94:10279–84.
    doi: 10.1073/pnas.94.19.10279pmc: PMC23353pubmed: 9294201google scholar: lookup
  48. Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol (1999) 155:331–6.
    doi: 10.1016/S0002-9440(10)65128-0pmc: PMC1866859pubmed: 10433925google scholar: lookup
  49. Bonnart C, Feuillet G, Vasseur V, Cenac N, Vergnolle N, Blanchard N. Protease-activated receptor 2 contributes to toxoplasma gondii-mediated gut inflammation. Parasite Immunol (2017) 39.
    doi: 10.1111/pim.12489pubmed: 28881035google scholar: lookup
  50. Gayle JM, Blikslager AT, Jones SL. Role of neutrophils in intestinal mucosal injury. J Am Vet Med Assoc (2000) 217:498–500.
    doi: 10.2460/javma.2000.217.498pubmed: 10953711google scholar: lookup
  51. Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev (2007) 87:545–64.
    doi: 10.1152/physrev.00012.2006pubmed: 17429041google scholar: lookup
  52. Grosche A, Freeman DE, Morton AJ, Polyak MM, Matyjaszek SA. Effects of ischemia and reperfusion on production of nitrotyrosine, activation of eosinophils, and apoptosis in the large colonic mucosa of horses. Am J Vet Res (2012) 73:53–61.
    doi: 10.2460/ajvr.73.1.53pubmed: 22204288google scholar: lookup
  53. Rötting AK, Freeman DE, Constable PD, Eurell JA, Wallig MA. Effects of ischemia and reperfusion on eosinophilic accumulation and distribution in mucosa of equine jejunum and colon. Am J Vet Res (2016) 77:534–9.
    doi: 10.2460/ajvr.77.5.534pubmed: 27111021google scholar: lookup
  54. Gao C, Liu S, Hu HZ, Gao N, Kim GY, Xia Y. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology (2002) 123:1554–64.
    doi: 10.1053/gast.2002.36581pubmed: 12404230google scholar: lookup
  55. Mueller K, Michel K, Krueger D, Demir IE, Ceyhan GO, Zeller F. Activity of protease-activated receptors in the human submucous plexus. Gastroenterology (2011) 141:2088–97.e1.
    doi: 10.1053/j.gastro.2011.08.034pubmed: 21875497google scholar: lookup
  56. Maeda K, Hirota M, Kimura Y, Ichihara A, Ohmuraya M, Sugita H. Proinflammatory role of trypsin and protease-activated receptor-2 in a rat model of acute pancreatitis. Pancreas (2005) 31:54–62.
    doi: 10.1097/01.mpa.0000163178.37050.0dpubmed: 15968248google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.